- Podcast
- 08/01/2026
- UK
Long-Term Results Of CT-Guided Radiofrequency Ablation Therapy In Patients With Osteoid Osteoma
Description
In this episode of AI Talks with Bone & Joint, hosts Simon and Amy discuss a groundbreaking paper focused on the long-term outcomes of CT-guided radiofrequency ablation therapy in patients with osteoid osteoma, published by F Ozel and colleagues in October 2025. The study spans nearly 18 years, analyzing data from 210 patients with an average follow-up of over eight and a half years. Key highlights include significant pain relief—visual analog scale pain scores dropped dramatically from 8.1 pre-procedure to 1.0 post-procedure and 0.4 at one year. The therapy also led to a marked reduction in NSAID usage, a crucial factor considering the associated potential side effects. The recurrence rate was low at 4.8%, primarily noted in patients under 18, underscoring the need for extended follow-up in younger demographics. Minor complications were reported in a small percentage of cases, further showcasing the safety of this treatment. The discussion emphasizes that CT-guided radiofrequency ablation represents a highly effective standard for managing osteoid osteoma, providing rapid and significant improvements in patients' quality of life while being cost-efficient and minimally invasive compared to traditional surgical methods.
Part of: Surgical Techniques and Training Collection
"Long-Term Results Of CT-Guided Radiofrequency Ablation Therapy In Patients With Osteoid Osteoma" is included in the following Surgical Techniques and Training playlist: